Cannabis use as a probable causative factor in the later development of schizophrenia;Cannabisgebruik waarschijnlijk oorzakelijke factor bij het ontstaan van latere schizofrenie

Nederlands Tijdschrift voor Geneeskunde

Volumn 147, Issue 44, 2003, Pages 2178-2183

  Smit, F ^a   Bolier, L ^a   Cuijpers, P ^a  

^a NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS;

ARTICLE; CANNABIS ADDICTION; DRUG ABUSE; HUMAN; LONGITUDINAL STUDY; MENTAL DISEASE; PSYCHOSIS; RISK FACTOR; SCHIZOPHRENIA;

CANNABIS; HUMANS; LONGITUDINAL STUDIES; MARIJUANA SMOKING; PSYCHOSES, SUBSTANCE-INDUCED; RISK FACTORS; SCHIZOPHRENIA;

EID: 0242330812     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Thornicroft G. Cannabis and psychosis. Is there epidemiological evidence for an association? Br J Psychiatry 1990;157:25-33.
2. Heeler H, Dingemans P, Linszen D. Cannabis en schizofrenie. Een literatuuronderzoek. Tijdschrift voor Psychiatrie 1992;34:699-708.
3. Johns A. Psychiatric effects of cannabis. Br J Psychiatry 2001;178: 116-22.
4. Hanak C, Tecco J, Verbanck P, Pelc I. Cannabis, mental health and dependence. In: Spruit I, editor. Cannabis 2002 report. Brussel: Ministry of Public Health; 2002. p. 63-9.
5. Murray RM, Grech A, Phillips P, Johnson S. What is the relationship between substance abuse and schizophrenia? In: Murray RM, Jones PB, Susser E, Os J van, Cannon M, editors. The epidemiology of schizophrenia. Cambridge: Cambridge University Press; 2003. p. 317-42.
6. Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self-reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 2002;325:1199-201.
7. Weiser M, Knobler HY, Noy S, Kaplan Z. Clinical characteristics of adolescents later hospitalised for schizophrenia. Am J Med Genet 2002;114:949-55.
8. Arseneault L, Cannon M, Poulton R, Murrey R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002;325:1212-3.
9. Fergusson DM, Horwood LJ, Swain-Cambell NR. Cannabis dependence and psychotic symptoms in young people. Psychol Med 2003; 33:15-21.
10. Os J van, Bak M, Hanssen M, Bijl RV, Graaf R de, Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 2002;156:319-27.
11. Patton GC, Coffey C, Carlin JB, Degenhardt L, Lynskey M, Hall W. Cannabis use and mental health in young people: cohort study. BMJ 2002;325:1195-8.
12. Rothman KJ, Greenland S, editors. Modern epidemiology. 2nd ed. Philadelphia: Lippincott-Raven; 1998.
13. Andreasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 1987;2(8574):1483-6.
14. Bijl RV, Zessen G van, Ravelli A, Rijk C de, Langendoen Y. The Netherlands Mental Health Survey and Incidence Study (NEMESIS): objectives and design. Soc Psychiatry Psychiatr Epidemiol 1998;33:581-6.
15. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders: DSM-III-R. 3rd rev. ed. Washington: APA; 1987.
16. Smeets RMW, Dingemans PMAJ. Composite International Diagnostic Interview (CIDI). Version 1.1. Genève: World Health Organization; 1993.
17. Smit F, Monshouwer K, Verdunnen J. Polydrug use among secondary school students: combinations, prevalences and risk-profiles. Drugs: education, prevention and policy 2002;9:355-65.
18. Bijl RV, Graaf R de, Ravelli A, Smit F, Vollebergh WAM. Gender and age specific first incidence of DSM-III-R psychiatric disorders in the general population: results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 2002;37:372-9.
19. Zwart WM de, Monshouwer K, Smit F. Jeugd en riskant gedrag, kerngegevens 1999: roken, drinken, drugsgebruik en gokken onder scholieren vanaf tien jaar. Utrecht: Trimbos-instituut; 2000.
20. Nationale Drugmonitor (NDM). Jaarbericht 2002. Utrecht: Bureau NDM; 2002.
21. Nationale Drugmonitor (NDM). Cannabis: feiten en cijfers 2003. Achtergrondstudie. Utrecht: Bureau NDM; 2003.
22. Os J van, Hanssen M, Bijl RV, Ravelli A. Strauss (1969) revisited: a psychosis continuum in the general population? Schizophrenia Research 2000;45:11-20.
23. Bijl RV, Zessen G van, Ravelli A. Psychiatrische morbiditeit onder volwassenen in Nederland: het NEMESIS-onderzoek. II. Prevalentie van psychiatrische stoornissen. Ned Tijdschr Geneeskd 1997; 141:2453-60.
24. Cuijpers P, Jonkers R, Weerdt I de, Jong A de. The effects of drug abuse prevention at school: The 'Healthy School and Drugs' project. Addiction 2002;97:67-73.